U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) or the Securities Exchange Act of 1934
Date of Report: June 5, 2002
NORICOM INC.
(Exact Name Of Registrant As Specified In Its Charter)
Commission File No. 000-32767
Nevada 86-1024812
(State or other Jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number.)
7373 N Scottsdale Road, Suite D215,
Scottsdale, AZ 85253.
480-941-4902
(Address, including zip code, including area code, and telephone number of
registrant's principal executive offices)
None
(Former name and former address, if changed since last report)
ITEM 5. OTHER EVENTS
Amendments to the Company's Articles of Incorporation
The Shareholders of the Company have approved an amendment to its Articles
of Incorporation.
The amendment is to Article I , and is made for the purpose of changing the name
of the Corporation from Noricom, Inc. to A J&J Pharma, Corporation. The name
change became effective on June 3, 2002. On June , June 5, 2002 the Corporation
filed with the Secretary of State of the State of Nevada a Certificate of
Amendment to its Articles of Incorporation, evidencing such name change.
The date of adoption of the above amendment to Articles I by the
Shareholders of this Corporation, is June 3, 2002.
Change of company address
In connection with the above amendment and events having taken place, the
Company has changed its address to PO Box 13087, Scotttsdale, Arizona
85267.
ITEM 7. FINANCIALS STATEMENTS AND EXHIBITS
Financial Statements: None
Exhibit 1 - Articles of Amendment
SIGNATURES
In accordance with Section 12 of the Securities Exchange Act of 1934, the
registrant caused this registration statement to be signed on its behalf by the
undersigned, who are duly authorized.
Registrant: Noricom, Inc.
Date: June 5, 2002
/s/ Kevin Ericksteen
-------------------------------
Keven Ericksteen
President and Director